Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Macy's, Inc. stock logo
M
Macy's
$23.66
-1.9%
$22.51
$11.77
$26.10
$6.23B1.464.81 million shs5.60 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.08
-0.2%
$25.21
$23.11
$28.75
$142.77B0.3545.18 million shs45.60 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Macy's, Inc. stock logo
M
Macy's
0.00%+4.44%-2.16%+21.16%+96.13%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+3.57%-0.69%-9.06%+2.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Macy's, Inc. stock logo
M
Macy's
$23.66
-1.9%
$22.51
$11.77
$26.10
$6.23B1.464.81 million shs5.60 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.08
-0.2%
$25.21
$23.11
$28.75
$142.77B0.3545.18 million shs45.60 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Macy's, Inc. stock logo
M
Macy's
0.00%+4.44%-2.16%+21.16%+96.13%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+3.57%-0.69%-9.06%+2.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Macy's, Inc. stock logo
M
Macy's
2.00
Hold$21.70-8.30% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.5013.64% Upside

Current Analyst Ratings Breakdown

Latest M and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetOutperform$34.00 ➝ $30.00
7/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetBuy$36.00 ➝ $35.00
7/10/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetNeutral$27.00 ➝ $26.00
7/8/2026
Macy's, Inc. stock logo
M
Macy's
Reiterated RatingHold (C+)
7/8/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetNeutral$30.00 ➝ $28.00
7/6/2026
Macy's, Inc. stock logo
M
Macy's
Reiterated RatingEqual WeightOverweight$30.00
7/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
DowngradeBuyHold$32.00 ➝ $28.00
7/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral$27.00
6/23/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingOutperform
6/22/2026
Macy's, Inc. stock logo
M
Macy's
Boost Price TargetHold$20.00 ➝ $25.00
6/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeUnderperformSector Perform$25.00
(Data available from 7/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Macy's, Inc. stock logo
M
Macy's
$22.62B0.28$5.80 per share4.08$18.28 per share1.29
Pfizer Inc. stock logo
PFE
Pfizer
$63.31B2.26$4.40 per share5.70$15.26 per share1.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Macy's, Inc. stock logo
M
Macy's
$642M$2.429.7810.16N/A2.94%13.68%3.88%9/2/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.158.80N/A11.83%19.44%8.41%8/4/2026 (Estimated)

Latest M and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.68N/AN/AN/A$14.42 billionN/A
6/3/2026Q1 2026
Macy's, Inc. stock logo
M
Macy's
$0.02$0.13+$0.11$0.23$4.61 billion$4.89 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Macy's, Inc. stock logo
M
Macy's
$0.773.25%+13.95%31.82%4 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.86%-13.20%131.30%16 Years

Latest M and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/24/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.15%7/24/20267/24/20269/1/2026
5/15/2026
Macy's, Inc. stock logo
M
Macy's
quarterly$0.19153.11%6/15/20266/15/20267/1/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Macy's, Inc. stock logo
M
Macy's
0.50
1.48
0.44
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
Macy's, Inc. stock logo
M
Macy's
87.36%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Macy's, Inc. stock logo
M
Macy's
1.05%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Macy's, Inc. stock logo
M
Macy's
90,134263.04 million260.28 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer Inc. $PFE Shares Bought by Swiss National Bank
Pfizer Inc. $PFE Stock Position Raised by AIA Group Ltd
Erste Group Bank Decreases Earnings Estimates for Pfizer
Pfizer Stock Near Lows But Analysts See Upside Ahead
Can Pfizer (NYSE:PFE) Strengthen Its Pipeline Story?
3 High-Yield Dividend Stocks to Buy and Hold
Pfizer (NYSE:PFE) Shares Sold Off Sen. Tommy Tuberville

New MarketBeat Followers Over Time

Media Sentiment Over Time

Macy's stock logo

Macy's NYSE:M

$23.66 -0.46 (-1.89%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$23.78 +0.11 (+0.47%)
As of 07/17/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY.

Pfizer stock logo

Pfizer NYSE:PFE

$25.08 -0.06 (-0.24%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$25.06 -0.01 (-0.06%)
As of 07/17/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.